XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity and Convertible Preferred Stock (Tables)
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of warrant activity
   Warrants   Weighted
Average
Exercise Price
   Total
Intrinsic
Value
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Outstanding as of December 31, 2022   444,796   $29.25    
      -
      3.20 
Outstanding as of March 31, 2023   444,796   $29.25    
-
    2.95 

 

Schedule of restricted stock awards activity
   Number of
Restricted
Stock Awards
   Weighted
Average
Grant Day
Fair Value
 
Nonvested at December 31, 2022   8,068   $5.64 
Vested   (8,068)   5.64 
Nonvested at December 31, 2022   
-
   $
-
 

 

Schedule of stock option activity
   Number of
Shares
   Weighted
Average
Exercise Price
   Total Intrinsic
Value
   Weighted
Average
Remaining
Contractual
Life (in years)
 
Outstanding as of December 31, 2022   31,193   $302.97   $
       -
         7.9 
Outstanding as of March 31, 2023   31,193   $302.97   $
-
    7.7 
Options vested and exercisable   25,311   $372.00   $
-
    7.4